GLP-1 Maker Sued Over Ads; Vaginal Estrogen; Melinda Gates Talks Perimenopause

(MedPage Today) -- Novo Nordisk sued rival drugmaker Eli Lilly, alleging false advertising claims about relative weight-loss drug performance. (Reuters via NBC News)
GLP-1 drug use surged from 2017 to 2022, jumping 230% in adults with diabetes...